找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Stereotactic Body Radiation Therapy; Principles and Pract Yasushi Nagata Book 2023Latest edition The Editor(s) (if applicable) and The Auth

[復制鏈接]
樓主: CHARY
41#
發(fā)表于 2025-3-28 14:57:09 | 只看該作者
Lung: Toxicitiesg, including radiation-induced lung toxicities, heart disease, brachial plexopathy, bronchial toxicities, esophageal toxicities, chest wall toxicities, and dermatitis. Knowledge on the toxicities is being accumulated and dose constraints for the organs at risk are getting established. By taking thes
42#
發(fā)表于 2025-3-28 18:55:25 | 只看該作者
43#
發(fā)表于 2025-3-28 23:43:09 | 只看該作者
Kidneyrly or have so severe medical comorbidities that they cannot be operated, and partial nephrectomy of patients with only one kidney may result in chronic kidney disease. Stereotactic body radiotherapy (SBRT) is widely used as a treatment method in which high local control can be obtained with minimal
44#
發(fā)表于 2025-3-29 05:17:37 | 只看該作者
45#
發(fā)表于 2025-3-29 10:56:57 | 只看該作者
Oligometstreatable..Various clinical trials have been conducted to develop curative local treatments, in addition to standard care or systemic chemotherapy. Local treatment of oligometastases should be selected to avoid affecting subsequent treatments, considering late toxicity and treatment outcomes. Stereo
46#
發(fā)表于 2025-3-29 14:12:05 | 只看該作者
Other Indicationsr, and metastatic tumors have been established in several aspects. Recently, the indications of SBRT have widely spread to other organs with advanced technical improvements. The treatment strategy, techniques, and clinical outcomes of SBRT for prostate cancer, pancreatic cancer, adrenal gland tumor,
47#
發(fā)表于 2025-3-29 17:44:18 | 只看該作者
48#
發(fā)表于 2025-3-29 21:01:04 | 只看該作者
49#
發(fā)表于 2025-3-30 01:29:01 | 只看該作者
Kidneyic kidney disease. Stereotactic body radiotherapy (SBRT) is widely used as a treatment method in which high local control can be obtained with minimal invasiveness, and it is often reported that high local control can be safely obtained even for renal cancer. Some techniques and results of SBRT for RCC will be presented and discussed here.
50#
發(fā)表于 2025-3-30 04:33:25 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 13:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
电白县| 密山市| 甘谷县| 麻江县| 鞍山市| 漳浦县| 柳河县| 馆陶县| 会宁县| 屯留县| 泸水县| 禄劝| 临西县| 铜川市| 永宁县| 托克逊县| 荆州市| 芜湖市| 崇明县| 郁南县| 通化市| 翁牛特旗| 行唐县| 塔城市| 大化| 大余县| 彭州市| 新竹市| 乌兰察布市| 榆林市| 孝昌县| 岢岚县| 河源市| 麟游县| 花莲县| 台东县| 乌兰察布市| 周宁县| 会东县| 永宁县| 万山特区|